These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29155052)

  • 1. Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.
    Gao D; Podrez EA
    Free Radic Biol Med; 2018 Feb; 115():57-67. PubMed ID: 29155052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linking modifications of HDL apoproteins by oxidized phospholipids: structural characterization,
    Gao D; Ashraf MZ; Zhang L; Kar N; Byzova TV; Podrez EA
    J Biol Chem; 2020 Feb; 295(7):1973-1984. PubMed ID: 31907281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of covalent modifications of proteins by oxidized phospholipids using a novel method of peptide enrichment.
    Gao D; Willard B; Podrez EA
    Anal Chem; 2014 Jan; 86(2):1254-62. PubMed ID: 24350680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein.
    Pankhurst G; Wang XL; Wilcken DE; Baernthaler G; Panzenböck U; Raftery M; Stocker R
    J Lipid Res; 2003 Feb; 44(2):349-55. PubMed ID: 12576517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative modification of HDL3 in vitro and its effect on PLTP-mediated phospholipid transfer.
    Huuskonen J; Olkkonen VM; Jauhiainen M; Sareneva T; Somerharju P; Ehnholm C
    Biochim Biophys Acta; 1998 Mar; 1391(2):181-92. PubMed ID: 9555005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
    Lu N; Xie S; Li J; Tian R; Peng YY
    Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic fate of chylomicron phospholipids and apoproteins in the rat.
    Tall AR; Green PH; Glickman RM; Riley JW
    J Clin Invest; 1979 Oct; 64(4):977-89. PubMed ID: 225354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.
    Shao B; Pennathur S; Heinecke JW
    J Biol Chem; 2012 Feb; 287(9):6375-86. PubMed ID: 22219194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities.
    Kontush A; Chapman MJ
    Curr Opin Lipidol; 2010 Aug; 21(4):312-8. PubMed ID: 20581677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.
    Hedrick CC; Castellani LW; Wong H; Lusis AJ
    J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
    Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipids mediated conversion of HDLs generates specific apoA-II pre-beta mobility particles.
    Wróblewska M; Kortas-Stempak B; Szutowicz A; Badzio T
    J Lipid Res; 2009 Apr; 50(4):667-75. PubMed ID: 19066403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of proteins adducted by lipid peroxidation products in plasma and modifications of apolipoprotein A1 with a novel biotinylated phospholipid probe.
    Szapacs ME; Kim HY; Porter NA; Liebler DC
    J Proteome Res; 2008 Oct; 7(10):4237-46. PubMed ID: 18778096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia.
    Arai K; Orsoni A; Mallat Z; Tedgui A; Witztum JL; Bruckert E; Tselepis AD; Chapman MJ; Tsimikas S
    J Lipid Res; 2012 Aug; 53(8):1670-8. PubMed ID: 22628616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen influences HDL-associated enzymes and reduces oxidized phospholipids levels in rats fed with a high-fat diet.
    Liu B; Zhao M; Xue J; Gu Q; Zhang X; Qin S
    Life Sci; 2021 Feb; 267():118945. PubMed ID: 33359745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.
    Witkowski A; Chan GKL; Boatz JC; Li NJ; Inoue AP; Wong JC; van der Wel PCA; Cavigiolio G
    FASEB J; 2018 Jun; 32(6):3149-3165. PubMed ID: 29401604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.
    Jin Z; Zhou L; Tian R; Lu N
    Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.